Home | ILSA HN

EXCELLENCE, QUALITY, AND INNOVATION IN CLINICAL RESEARCH

GET TO KNOW US

Founded in 2019 by 2 medical professionals with a single vision, Investigación sin Límites S. de R.L. has established itself as a key institution in clinical research in Honduras. Despite many challenges, such as the COVID-19 pandemic, the company has grown with perseverance and dedication, positioning itself among the three most important research centers in the country; today we are synonymous with excellence, quality, and innovation, significantly contributing to national scientific and medical development.

More information

RESEARCH AREAS

Internal Medicine

Pediatrics

Immunology

Endocrinology

Oncology

Gastroenterology

Rheumatology

Cardiology

SERVICES

CLINICAL RESEARCH

Development of clinical studies focused on the evaluation of new treatments, vaccines, and medical alternatives with strict ethical and regulatory compliance.

EMERGENCY

Immediate medical attention for patients requiring timely evaluation and treatment in priority health situations.

MEDICAL ATTENTION

Consultation and medical follow-up conducted by health professionals committed to comprehensive and quality care.

LABORATORY

Clinical laboratory services with reliable diagnostic support and sample processing under high-quality standards.

What is a Clinical Trial?

A clinical trial is a medical research study conducted to evaluate the safety and effectiveness of new treatments, vaccines, or medications that help improve people's health.

Benefits of participation

Medical and dental care, health education, growth and development monitoring, etc.

Patient Safety

The safety of participants is our priority. All studies are approved by an Independent Ethics Committee, the Health Regulatory Agency, and the General Directorate of Regulatory Framework Surveillance, and are conducted by Specialist Physicians as Principal Investigators, who comply with strict national and international standards of ethics and biosecurity.

Available Studies

VYF04 (Yellow Fever) for infants aged 9-24 months and PSK00029 (Pneumococcus) for infants aged 42-89 days, PSK03, PSK05, PSK00029 (Pneumococcus) pediatric population aged 42-89 days; VAN013 (Meningococcus)

More information

Animación de Porcentaje

participant retention in selected studies

INSTITUTIONAL METRICS

10

Studies Conducted

1,000+

Participants

7

Years of Experience

10

Specialties

SOCIAL IMPACT

At Investigación sin Límites S. de R. L., we contribute to public health through the development of pediatric studies, supporting the development of medications and vaccines, directly benefiting participating families.

During the development of each study, the medical staff works alongside the parents, providing specialized care with accurate diagnoses, strengthening community trust, and contributing to the prevention of infectious diseases.

We reaffirm our commitment to contribute to community well-being through high-value scientific research, generating data that benefits patients and public health in Honduras.

During the follow-up of each study, we provide timely medical care with quality and warmth, offering the best clinical results for our participants.

Sponsors and CROs

Contact us

We would love to hear from you!

Please feel free to contact us if you have any questions, comments, or need assistance. Our team is here to assist you and will respond as soon as possible.